Multiplex Assay Kit for Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ,etc. by FLIA (Flow Luminesc
  • Multiplex Assay Kit for Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ,etc. by FLIA (Flow Luminesc

Multiplex Assay Kit for Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ,etc. by FLIA (Flow Luminesc

Ref: CC-LMR870Hu
OCIA Domain Containing 2; Ovarian carcinoma immunoreactive antigen-like protein

Información del producto

Especificidad:

This assay has high sensitivity and excellent specificity for detection of Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Click here for manual in PDF

Click here for OD image

Información adicional
Applications FLIA Kit for Antigen Detection.
Detection Range 0.02-20ng/mL
Sensitivity The minimum detectable dose of this kit is typically less than 0.007 ng/mL
Specificity

Research Area Tumor immunity
Organism species Homo sapiens (Human)
Alternative Names OCIA Domain Containing 2
Item Name Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2
Assay Length 3h
Method Double-antibody Sandwich
Sample Type Tissue homogenates, cell lysates and other biological fluids.
Format 48T, 96T, 96T×5, 96T×10, 96T×100
Test Principle Analyte-specific antibodies are pre-coated onto color-coded microparticles. Microparticles, standards, and samples are pipetted into wells and the immobilized antibodies bind the analytes of interest. After washing away any unbound substances, a biotinyla
Assay procedure summary 1. Preparation of standards, reagents and samples before the experiment
UniProt ID Q56VL3